公司资料
Syros Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- SYRS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年10月2日
—
市值
股价为何变动
截至 2026年10月2日，SYRS 股价变化不大，收于 $0.0004。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Syros Pharmaceuticals is a precision-oncology company focused on gene regulation and transcriptional control in cancer. Its platform targets the biology that drives tumor growth and resistance.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Syros sits in specialty oncology biotechnology.
商业模式特征
The company depends on clinical data, target validation, and the ability to create a durable oncology story.
生物医药行业定位
Syros is a small-cap oncology catalyst name whose valuation depends on early data and strategic progress.
未来催化剂
- Syros’s catalysts are tamibarotene-related oncology updates and any strategic step that clarifies the company’s future. The story remains dependent on whether there is still enough clinical value left.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。